Functional characterization of mutant α-galactosidase A identified from Korean patients with Fabry disease.

被引：0
|
作者：
Kim, SS
Kim, Y
Kim, GH
Yoo, HW
机构：
[1] Asan Med Ctr, Genom Res Ctr Gen Dis, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pediat, Seoul, South Korea
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2003年 / 73卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
1615
引用
收藏
页码：446 / 446
页数：1
相关论文
共 50 条
  • [1] Functional characterization and chemical chaperones effect on alpha galactosidase gene mutations identified in Fabry Italian patients
    Filom, C.
    Caciotti, A.
    Carraresi, L.
    Caviechi, C.
    Parini, R.
    Feriozzi, S.
    Poisetti, P.
    Garman, S.
    Guerrini, R.
    Zammarchi, E.
    Donati, M. A.
    Morrone, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 113 - 113
  • [2] Mutant α-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity:: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin
    Ishii, Satoshi
    Chang, Hui-Hwa
    Kawasaki, Kunito
    Yasuda, Kayo
    Wu, Hui-Li
    Garman, Scott C.
    Fan, Jian-Qiang
    BIOCHEMICAL JOURNAL, 2007, 406 (02) : 285 - 295
  • [3] Effects of a chemical chaperone on genetic mutations in α-galactosidase A in Korean patients with Fabry disease
    Park, Jung-Young
    Kim, Gu-Hwan
    Kim, Sung-Su
    Ko, Jung Min
    Lee, Jin-Joo
    Yoo, Han-Wook
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2009, 41 (01): : 1 - 7
  • [4] Effects of a chemical chaperone on genetic mutations in α-galactosidase A in Korean patients with Fabry disease
    Jung-Young Park
    Gu-Hwan Kim
    Sung-Su Kim
    Jung Min Ko
    Jin-Joo Lee
    Han-Wook Yoo
    Experimental & Molecular Medicine, 2009, 41 : 1 - 7
  • [5] A novel a-galactosidase a mutant (M42L) identified in a renal variant of Fabry disease
    Rosenthal, D
    Lien, YHH
    Lager, D
    Lai, LW
    Shang, SH
    Leung, N
    Fervenza, FC
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (05) : E85 - E89
  • [6] Fabry's disease.: An orphan disease with a new solution:: enzymatic replacement with α-galactosidase
    Selgas, R
    de Lorenz, AG
    Valdés, F
    Beck, M
    NEFROLOGIA, 2001, 21 (05): : 443 - 447
  • [7] Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young
    De Brabander, Isabel
    Yperzeele, Laetitia
    Ceuterick-De Groote, Chantal
    Brouns, Raf
    Baker, Robert
    Belachew, Shibeshih
    Delbecq, Jean
    De Keulenaer, Gilles
    Dethy, Sophie
    Eyskens, Francois
    Fumal, Arnaud
    Hemelsoet, Dimitri
    Hughes, Derralynn
    Jeangette, Sandrine
    Nuytten, Dirk
    Redondo, Patricia
    Sadzot, Bernard
    Sindic, Christian
    Sheorajpanday, Rishi
    Thijs, Vincent
    Van Broeckhoven, Christine
    De Deyn, Peter P.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (07) : 1088 - 1093
  • [8] Identification of novel alpha-galactosidase A mutations causing Fabry disease.
    Shabbeer, J
    Ashley, G
    Eng, C
    Yasuda, M
    Desnick, R
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 271 - 271
  • [9] Altered substrate specificity of mutant beta-galactosidase in patients with Morquio B disease.
    Okumiya, T
    Sugiura, T
    CLINICAL CHEMISTRY, 2001, 47 (06) : A30 - A30
  • [10] A structural study of mutant forms of the α-galactosidase enzyme: insight into Fabry disease
    Sugawara, K.
    Ohno, K.
    Saito, S.
    Sakuraba, H.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 : S135 - S136
12345